Commodore Capital as of June 30, 2023
Portfolio Holdings for Commodore Capital
Commodore Capital holds 26 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Merus N V (MRUS) | 11.8 | $105M | 4.0M | 26.33 | |
| Vera Therapeutics Cl A (VERA) | 9.8 | $88M | 5.5M | 16.05 | |
| Akero Therapeutics (AKRO) | 8.8 | $78M | 1.7M | 46.69 | |
| Xenon Pharmaceuticals (XENE) | 8.0 | $71M | 1.8M | 38.50 | |
| Cogent Biosciences (COGT) | 7.4 | $66M | 5.6M | 11.84 | |
| Miragen Therapeutics (VRDN) | 5.9 | $52M | 2.2M | 23.79 | |
| Ambrx Biopharma Sponsored Ads | 5.9 | $52M | 3.2M | 16.46 | |
| Vaxcyte (PCVX) | 5.7 | $51M | 1.0M | 49.94 | |
| Nuvalent Inc-a (NUVL) | 5.4 | $49M | 1.2M | 42.17 | |
| Enliven Therapeutics (ELVN) | 5.4 | $48M | 2.3M | 20.41 | |
| Cabaletta Bio (CABA) | 3.4 | $31M | 2.4M | 12.91 | |
| Cymabay Therapeutics | 2.5 | $22M | 2.0M | 10.95 | |
| Arrowhead Pharmaceuticals (ARWR) | 2.4 | $22M | 610k | 35.66 | |
| Celldex Therapeutics Com New (CLDX) | 2.4 | $21M | 632k | 33.93 | |
| Syndax Pharmaceuticals (SNDX) | 2.3 | $21M | 998k | 20.93 | |
| Ideaya Biosciences (IDYA) | 2.0 | $18M | 775k | 23.50 | |
| Immunovant (IMVT) | 1.9 | $17M | 900k | 18.97 | |
| Adverum Biotechnologies | 1.8 | $16M | 10M | 1.59 | |
| Celcuity (CELC) | 1.8 | $16M | 1.4M | 10.98 | |
| Kura Oncology (KURA) | 1.7 | $15M | 1.4M | 10.58 | |
| Alpine Immune Sciences | 1.5 | $14M | 1.3M | 10.28 | |
| Day One Biopharmaceuticals I (DAWN) | 1.0 | $8.8M | 740k | 11.94 | |
| Third Harmonic Bio (THRD) | 0.5 | $4.8M | 993k | 4.81 | |
| Kalvista Pharmaceuticals (KALV) | 0.3 | $2.8M | 313k | 9.00 | |
| Aeglea Biotherapeutics | 0.1 | $1.3M | 2.9M | 0.45 | |
| Dbv Technologies S A Sponsored Adr | 0.0 | $176k | 93k | 1.90 |
